What Makes Us Different?

Our differentiator in this area is our vast experience ranging from exploratory to pivotal trials across all modalities, including ADC, bispecific and advanced therapies. We have extensive site resources including National Cancer Centers,  academic sites and Regional Medical Centers throughout China and the United States. We have access to nationally recognized oncology experts in both solid tumors and hematology, enabling rapid medical feasibility assessments tailored to specific indication requirements, as well as efficient site initiation through strong partnerships with leading clinical trial sites.